Focus Areas

Innovative Neuro Research


Recurrent, unprovoked seizures

  • Spontaneous seizure development
  • Post Traumatic Epilepsy
  • Specializing in reproducing seizures in the lab


Affecting neurons in the brain

  • Animal Model Development
  • Alzheimer's
  • Parkinson's


Innovative Techniques

  • Neurodegenerative diseases
  • Epilepsy
  • Traumatic brain injury

Other Research

Growing interest in

  • Biomarker development
  • Non-invasive Nuerostimulation
  • Human Microbiome ``The Second Brain``

Patents Pending

Expesicor Pipeline
Current Projects at Expesicor
People with Epilepsy
Traumatic Brain Injury (TBI) cases each year
People with Alzheimer's and Parkinson's
Meet the Team

Expesicor Leadership

Braxton Norwood PhD
CEO & Director of Neuroscience
Neuroscientist with substantial experience in epilepsy R&D. NIH Young Investigator Award. CURE Foundation Challenge Award.
David Booth
COO & Chairman of the Board
Serial entrepreneur and investor
Expect a response within 48 hours
Contact Us

“Epilepsy R&D is long overdue for a breakthrough, and the KaL method may be just that.”

Tom Swanson MD, Director of the MT Comprehensive Epilepsy Center

July Update – Expesicor receives a $101,250 grant from the Montana Department of Commerce.

Access the recommendation on F1000